X0306 4 2016-05-31 0001014739 BioScrip, Inc. BIOS 0001286630 GOLDING DAVID W C/O BIOSCRIP INC. 1600 BROADWAY, SUITE 950 DENVER CO 80202 1 Common Stock, $.0001 Par Value 2016-05-31 4 M 0 10000 0 A 40000 D Common Stock, $.0001 Par Value 2016-05-31 4 D 0 10000 2.70 D 30000 D Phantom Stock 2016-05-31 4 M 0 10000 D Common Stock, $.0001 Par Value 10000 0 D Under the terms of the market-based cash award, as publicly filed, each share of "phantom stock" is the economic equivalent of one share of the Issuer's common stock, par value $0.0001 per share ("Common Stock"). Each share of "phantom stock" granted pursuant to the market-based cash award was entitled to a cash payment equal to the fair market value of a share of Common Stock as of the vesting date, which was $2.70 based on the closing market price of the Common Stock on May 31, 2016. The cash settlement of the market-based cash award is reported solely for purposes of Form 4 as the deemed disposition of the market-based cash award and a deemed simultaneous acquisition and disposition of 10,000 shares of Common Stock. The market-based cash award vested on May 31, 2016, the business day immediately preceding the date of the Issuer's 2016 annual meeting of stockholders, because the reporting person served as a director of the Issuer as of such date. If unvested on the vesting date, the market-based cash award would have expired on May 31, 2016. /s/ David W. Golding 2016-06-02